Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia.

To assess and compare the levels of functioning in patients with major depressive disorder treated with either duloxetine with a daily dose of =60 mg or a selective serotonin reuptake inhibitor (SSRI) as monotherapy for up to 6 months in a naturalistic setting in East Asia. In addition, this study e...

ver descrição completa

Detalhes bibliográficos
Autores: Novick D, Montgomery W, Haro JM, Moneta MV, Zhu G, Yue L, Hong J, Dueñas H, Brugnoli R
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2016
País:España
Recursos:Fundació Sant Joan de Déu
Repositorio:r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
OAI Identifier:oai:fsjd.fundanetsuite.com:p9187
Acesso em linha:https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=9187
Access Level:acceso abierto
Palavra-chave:SSRI, antidepressant, depression, duloxetine, functioning
Descrição
Resumo:To assess and compare the levels of functioning in patients with major depressive disorder treated with either duloxetine with a daily dose of =60 mg or a selective serotonin reuptake inhibitor (SSRI) as monotherapy for up to 6 months in a naturalistic setting in East Asia. In addition, this study examined the impact of painful physical symptoms (PPS) on the effects of these treatments.